NCT01349270View on ClinicalTrials.gov

Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Demyelinating Polyneuropathy
Interventions
DRUG

Immunoglobulin perfusion

patient who received monthly 2g/kg intravenous cure of immunoglobulin

DRUG

Prednisone

patient who received 0,8mg/kg/day of prednisone progressively tapered over 6 months

Trial Locations (11)

13000

Chu Marseille, Marseille

21000

Chu Dijon, Dijon

26000

Centre hospitalier de Valence, Valence

38000

CHU Grenoble, Grenoble

42100

Chu Saint-Etienne, Saint-Etienne

44000

Chu Nantes, Nantes

54000

Chu Nancy, Nancy

63000

CHU Clermont-Ferrand, Clermont-Ferrand

67000

Chu Strasbourg, Strasbourg

69000

Hôpital Neurologique de Lyon, Lyon

06000

CHU Nice, Nice

All Listed Sponsors
collaborator

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT01349270 - Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg | Biotech Hunter | Biotech Hunter